Sunscreen Rule Will Cost Four Times FDA’s Prediction, Industry Tells OMB
This article was originally published in The Tan Sheet
Executive Summary
FDA's low-ball estimate of the cost to industry from the final OTC sunscreen monograph – a quarter of the amount manufacturers anticipate – relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests.
You may also be interested in...
Industry Groups Shine Light On “Helps Prevent” Claim In Sunscreen Comments
Sunscreen labeling that claims the product "helps prevent" premature skin aging, cancer and other damage does not suggest sunscreen alone protects against these conditions, but in fact informs consumers that "complementary measures" are needed for adequate protection, according to trade groups' comments on FDA's proposal to amend the sunscreen final monograph
Still Can’t Cancel That Gym Membership? FTC Proposes One Negative Option Rule To Rule Them All
The FTC published a notice of proposed rulemaking on 23 March to update its 1973 Negative Option Rule, which has become obsolete vis-à-vis new marketing strategies in today’s digital world. Proposed amendments would clarify, expand and consolidate negative option-related provisions currently dispersed across different FTC laws and regulations.
L’Oreal Joins Heavyweights Tackling Sustainable Surfactants With Geno Biotech
L’Oreal, Kao and Unilever have partnered with Genomatica, Inc. (Geno) to develop sustainable surfactants by replacing feedstocks such as palm oil and fossil fuels with biotech alternatives.